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ABSTRACT 
Objective To assess the diagnostic and clinical contribution of in utero magnetic 
resonance (iuMR) imaging in fetuses diagnosed with abnormalities of the posterior 
fossa as the only intracranial abnormality recognised on antenatal ultrasonography 
(USS). 
Methods We report a sub-group analysis of fetuses with abnormalities of the posterior 
fossa diagnosed on antenatal USS (with or without ventriculomegaly) from the 
MERIDIAN cohort who had iuMR imaging within 2 weeks of USS and outcome 
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reference data were available. The diagnostic accuracy of USS and iuMR are reported 
as well as indicators of diagnostic confidence and effects on prognosis and clinical 
management. 
Results Abnormalities confined to the posterior fossa according to USS were found in 
81 fetuses (67 with parenchymal and 14 with CSF-containing lesions).  The overall 
diagnostic accuracy for detecting an isolated posterior fossa abnormality was 65% for 
USS and 88% for iuMR (difference=22%, 95% CI: 14.0 to 30.5%, p<0.0001). There 
was an improvement in ‘appropriate’ diagnostic confidence as assessed by a score-
based weighted average’ method (p<0.0001) and a three-fold reduction in ‘high 
confidence but incorrect diagnoses’ was achieved by using iuMR imaging. The 
prognostic information given to the women after iuMR imaging changed in 44% of 
cases and the overall effect of iuMR on clinical management was considered to be 
‘significant’, ‘major’ or ‘decisive’ in 35% of cases.  
Conclusions Our data suggests that any woman whose fetus has a posterior fossa 
abnormality as the only intracranial finding on USS should have iuMR imaging for 
further evaluation. This is on the basis of improved diagnostic accuracy and confidence 
which has substantial effects on the prognostic information given to women and 
changes in clinical management. 
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INTRODUCTION 
In our previous two published papers related to the MERIDIAN study, we reported sub-
groups analyses relating to the investigation of fetuses with apparent isolated 
ventriculomegaly1 and isolated abnormalities of the corpus callosum (failed 
commisuration)2 detected on antenatal ultrasonography (USS). In both cases we 
concluded that in utero MR (iuMR) imaging is a powerful adjunct to USS and improves 
diagnostic accuracy, diagnostic confidence and has a positive clinical impact in a high 
proportion of cases. The third sub-group studied in this fashion, and reported here, 
concerns the antenatal USS detection of brain abnormalities apparently confined to the 
posterior fossa. This includes abnormalities of the cerebellum, brain stem and associated 
CSF-containing spaces. 
This group is different from the previous two, inasmuch as the fetal medicine focus 
groups that recommend the sub-group analysis recognized that it was likely that the 
diagnostic performance of USS would be worse than iuMR imaging. This is in contrast 
to the fetuses with isolated ventriculomegaly and corpus callosum abnormalities in 
which the focus groups predicted (incorrectly) would be diagnosed accurately by USS 
in most cases. 
This paper reports the diagnostic accuracy and confidence of USS and iuMR for 
detecting posterior fossa abnormalities and, like the two previous studies, also looks for 
changes in prognostic information and clinical management of pregnant women brought 
about by including iuMR imaging in the diagnostic pathway. 
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METHODS 
All of the cases reported in this paper were recruited into the MERIDIAN study and the 
overarching methodology of the MERIDIAN study is reported elsewhere3 but the parts 
relevant to this paper are summarised here. Recruitment was from 16 fetal medicine 
units in the UK and inclusion criteria for the main study were – pregnant women aged 
≥16 years whose fetus had a brain abnormality detected by USS at a gestational age of 
18 weeks or more, with no contraindications to iuMR and who was willing to provide 
written, fully informed consent to enter the study. This subgroup analysis describes 
those fetuses with abnormalities confined to the posterior fossa (with or without 
associated ventriculomegaly), specifically those involving the brainstem or cerebellum 
(‘parenchymal abnormalities’) and those involving ‘CSF-containing’ lesions. Examples 
of parenchymal lesions include Dandy-Walker spectrum malformations, Chiari 2 
malformations and cerebellar hypoplasia, whilst CSF-containing lesions include 
enlarged cisterna magna (CM), Blake’s pouch cyst and arachnoid cysts. 
 
Antenatal imaging with ultrasonography and in utero MR imaging 
The USS studies were performed by appropriately trained NHS consultants in fetal 
medicine and, after consent was obtained, each brain abnormality was listed using 
nomenclature from the “ViewPoint” antenatal ultrasound reporting software (GE 
Healthcare, Chalfont St Giles UK) along with an assessment of certainty of diagnosis 
for each brain abnormality using a 5 point Likert scale4. Subsequently, the women had 
an iuMR examination performed on a 1·5T superconducting clinical MR system at one 
of six centres. The base requirement for the iuMR study was T2-weighted images of the 
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fetal brain in the three orthogonal planes and a T1-weighted ultrafast sequence in at 
least one plane (usually axial).  The reporting radiologist was aware of the diagnoses 
and the level of certainty made on USS from the study paperwork but also had access to 
the full clinical USS report. The radiologist was required to comment on each brain 
abnormality recognised on USS (using ‘diagnosis excluded’ if the finding was not 
present on iuMR) and added extra anatomical diagnoses where appropriate onto a 
similar form as used for USS. Each entry was accompanied by an indicator of 
confidence using the same Likert scale as the USS assessment.   
 
Outcome reference data and assessment of diagnostic accuracy 
In cases where pregnancy continued and the child survived, outcome reference data 
(ORD) was obtained from the clinical notes based on a diagnoses made on postnatal 
neuroimaging studies up to the age of six months. In cases of termination of pregnancy 
(TOP), stillbirth or neonatal deaths the ORD was based on autopsy and/or post-mortem 
MR imaging. An independent paediatric neuroradiologist determined whether a full 
review of ORD by a Multidisciplinary Independent Expert Panel (MIEP) was required. 
Full review was required unless there was complete and unequivocal agreement 
between the anatomical findings on USS, iuMR and the ORD. The MIEP consisted of 
three NHS consultants (neuroradiologist, fetal medicine consultant, and paediatric 
neurologist) from a centre that did not recruit into MERIDAN and they were asked to 
judge whether the USS-based diagnoses and iuMR-based diagnoses had complete 
agreement with the ORD. The primary analysis in MERIDIAN centred on participants 
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who underwent iuMR within 14 days of USS and for whom ORD was available and 
consisted of a calculation of diagnostic accuracy for USS and iuMR studies defined as;  
[True positives + True negatives]/Total number of cases  
Diagnostic accuracies were calculated for USS and iuMR and compared with ORD 
using McNemar’s.  
Assessment of diagnostic confidence 
In line with the main paper the first analysis of diagnostic confidence simply described 
the proportion of USS and iuMR diagnoses made with high and low confidence that 
were either correct or incorrect. ‘High confidence’ diagnoses were defined as 70% or 
90% certainties and low confidence diagnoses were 10%, 30% or 50% certainties for 
the purposes of this analysis.  
Our previous publication5 describes the significant limitations of the conventional 
assessments of diagnostic confidence, even if the Omary correction6 is used.  The major 
limitation occurs because those methods do not require confirmation that the diagnoses 
are either correct or incorrect (i.e. no ORD are required). All of the cases in this study 
have ORD and we have chosen to use the ‘score-based weighted average’ method 
described by Ng and Palmer7 as our preferred method of describing ‘appropriate’ 
diagnostic confidence. This approach uses not only diagnostic confidence assessments 
but also indicators of diagnostic accuracy as provided by the MIEP, specifically: was 
the overall diagnosis correct for iuMR, was the overall diagnosis correct for USS, which 
imaging method described the most severe pathology. This aspect was combined with a 
binary assessment of diagnostic confidence as either ‘high’ or ‘low’ as described above.  
An algorithm modified from Ng and Palmer7 (Figure 1) was used to define a route label 
for each case and hence derive a route score ranging from -4 to +4. Zero indicates no 
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change in ‘appropriate’ confidence, positive values indicate a benefit from iuMR 
imaging and negative values indicate that iuMR imaging had a detrimental effect on 
appropriate diagnostic confidence and the larger the value the greater the effect. The 
mean, standard deviation and 95% confidence intervals were calculated and one sample 
t-tests were carried out to determine if the calculated scores differed from zero. 
 
Assessment of effects on prognosis and clinical management 
MERIDIAN collected data from the fetal medicine specialists about any changes in 
clinical management brought about by iuMR as described in detail elsewhere3, but to 
summarise they were asked if iuMR imaging: a) provided extra diagnostic information, 
b) led to a change in prognosis and c) led to a change in management (including if TOP 
was offered as a management option). With respect to analysis of prognostic 
information, the fetal medicine subspecialists were asked to define what prognostic 
information was given to the woman on the basis of the USS scan (but before iuMR) 
based on the following five categories:   
1) Normal - no worse than the risk to a fetus without a demonstrable brain 
abnormality  
2) Favourable - Normal neurological outcome expected in >90% of cases  
3) Intermediate - Normal neurological outcome expected in 50 to 90% of cases  
4) Poor - Normal neurological outcome expected in <50% of cases  
5) Unknown  
At the next consultation with the woman (where the iuMR report was available) the 
clinician recorded the updated prognostic information using the same five categories. 
For the purposes of description in this report we describe if the prognosis remained the 
same, worsened or improved after iuMR. This approach is straightforward when 
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prognoses were in groups 1) to 4) or if the prognosis was ‘Unknown’ on both USS and 
iuMR. Difficulties arise when the prognosis on one imaging method was given as 
‘unknown’ but specified as 1) to 4) on the other. We have elected to interpret: 
• USS prognosis ‘unknown’, iuMR prognosis ‘Normal’ or ‘Favourable’ = 
improved prognosis 
• USS prognosis ‘unknown’, iuMR prognosis ‘Intermediate’ = no change in 
prognosis 
• USS prognosis ‘unknown’, iuMR prognosis ‘Poor’ = worse prognosis 
• USS prognosis  ‘Normal’ or ‘Favourable’, MR prognosis ‘Unknown’ = worse 
prognosis 
• USS prognosis  ‘Intermediate’, MR prognosis ‘Unknown’ = no change in 
prognosis 
• USS prognosis  ‘Poor’, MR prognosis ‘Unknown’ = no change in prognosis 
Clinicians were also asked if TOP was offered because the abnormalities on USS only 
were sufficient to consider that option under Ground E of the Abortion Act (section 
1(1)(d) – substantial risk of serious mental or physical handicap).8 They were 
subsequently asked if the previous decision about offering TOP was still valid after the 
iuMR information was available.  
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RESULTS 
Intracranial abnormalities confined to the posterior fossa were diagnosed on USS in 
81/570 (14.2%) fetuses from the MERIDIAN cohort. 57/81 (70.4%) had their iuMR 
study between 18-23 weeks in fetuses and 24/81 (29.6%) at ≥24 week’s gestational age.  
A parenchymal abnormality confined to the posterior fossa was diagnosed on USS in 
67/81 fetuses and a CSF-containing abnormality in 14/81.  Associated ventriculomegaly 
was found on USS in 25/81 (31%) of cases overall and was present in 20% of the 
fetuses with cerebellar hypoplasia, 29% with Dandy-Walker spectrum abnormalities and 
52% of fetuses with Chiari 2 malformations. 
 
Diagnostic accuracy 
The diagnostic accuracy data for the sub-group of fetuses with posterior fossa 
abnormalities is shown in table 1. The label ‘any abnormality of the posterior fossa’ 
does not distinguish between the type of posterior fossa abnormality, therefore incorrect 
diagnoses occur either when the ORD was normal or if a brain abnormality outside the 
posterior fossa was confirmed on ORD.  Using that definition, USS had an overall 
diagnostic accuracy of 65.4% and the 28 diagnostic errors in that group are described in 
table 2. ORD reported a normal brain in 18/28 of the USS errors and other 
supratentorial brain abnormalities in 10/28 of the USS errors (the other brain 
abnormalities consisted of: 6 agenesis or hypogenesis of the corpus callosum, 2 cortical 
formation abnormalities, 2 acquired pathology). Analysis of the iuMR imaging of those 
cases gave a diagnostic accuracy of 87.7%, demonstrating an improvement in diagnostic 
accuracy of 22.3% (95% CI: 14.0 to 30.5%, p<0.0001) over USS. The 10 errors made 
on iuMR consisted of eight cases in which the ORD was normal and two cases in which 
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iuMR imaging failed to detect an abnormality of the corpus callosum shown on ORD. 
Example cases of agreements and disagreements are shown in figures 2-5. 
Parenchymal abnormalities 
67/81 (82.7%) of the USS-based diagnoses described a ‘parenchymal abnormality’ of 
the posterior fossa and the specific diagnoses on USS were: 
• Cerebellar hypoplasia in 25/67 (38%) - vermian hypoplasia in 15 fetuses and 
hypoplasia of the cerebellar hemispheres in 10 fetuses 
• Dandy-Walker spectrum abnormalities in 21/67 (31%) 
• Chiari 2 malformation in 21/67 (31%) 
The label ‘parenchymal abnormality’ in table 1 requires the exact pathological diagnosis 
of the posterior fossa abnormality to be correct when compared with ORD and ignores 
the presence or absence of other brain abnormalities. As such, USS made the correct 
specific anatomical diagnosis in 54/67 fetuses (diagnostic accuracy 80.6%) and iuMR 
provided the correct diagnosis in 64/67 fetuses (diagnostic accuracy 95.5%). The 
difference in diagnostic accuracy was 14.9% (95% CI: 5.7 to 24.1%, p=0.002) in favour 
of iuMR. 
CSF-containing abnormalities 
14/81 of the diagnoses made on USS involved a ‘CSF containing abnormality’, which 
consisted of eight fetuses with an enlarged CM and six fetuses with abnormal cystic 
structures (four arachnoid cysts and two unspecified). 3/14 of the cases with an USS 
diagnosis of a ‘CSF abnormality’ were correct when compared with ORD (diagnostic 
accuracy 21.4%). The ORD diagnoses in the 11/14 cases of incorrect diagnoses on USS 
consisted of ‘no brain abnormality’ in eight fetuses, failed commissuration in two cases 
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and duro-venous thrombosis with ectasia9 in one case (Figure 6). The iuMR studies in 
those 14 fetuses provided the correct diagnosis in 8/14 cases (diagnostic accuracy 
57.1%) with a difference in favour of iuMR 35.7% (95% CI -1.6% to 73.0%, p=0.0625). 
All of the errors on iuMR imaging were cases in which a CSF-containing abnormality 
was diagnosed but not confirmed on ORD, although a corpus callosum abnormality was 
also missed in one case.  
 
Diagnostic confidence 
Figure 7 presents the proportions of correct and incorrect diagnoses made with high and 
low diagnostic confidence. High confidence diagnoses were made in 85% of fetuses on 
USS and 91% of fetuses on iuMR, an increase of 6%. In 17/81 cases (21% of the entire 
sub-group) a high confidence diagnoses was made on USS that was found to be 
incorrect on ORD in comparison with 6/81 (7%) on iuMR imaging, indicating a 3-fold 
reduction. 5/81 (6%) low confidence diagnoses were correct on USS, whilst 4/81 (5%) 
of low confidence diagnoses were correct on iuMR imaging. As described in the 
Methods section, diagnostic accuracy data was used in conjunction with diagnostic 
confidence data in order to calculate a ‘score-based weighted average’ value for each 
case as shown in figure 8. In 49/81 cases (60%) the score was 0 indicating that iuMR 
had no effect on diagnostic confidence in those cases, whilst the score was negative in 
8/81 cases (10%) indicating a deleterious effect of iuMR on ‘appropriate’ diagnostic 
confidence (Figure 8). In 24/81 cases (30%) the score was positive indicating an 
‘appropriate’ improvement in diagnostic performance. Formal analysis of the score-
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based weighted average graph indicates a mean difference of +0.70 (95% CI +0.36 to 
+1.05, p<0.0001) indicating an improvement in ‘appropriate’ diagnostic performance.  
 
Prognosis and clinical management  
There was incomplete prognostic/clinical management data in 3/81 cases, all from the 
‘parenchymal abnormality’ group. In the 78 cases in which complete 
prognostic/management data was available, fetal maternal consultants said that iuMR 
imaging provided extra diagnostic information in 38/78 fetuses (49%) compared with 
USS. This included 5/14 (36%) from the ‘CSF abnormality’ group and 33/64 (52%) 
from the ‘parenchymal abnormality’ group. The prognostic information category given 
to women after iuMR imaging changed in 34/78 (44%) cases. In 20 fetuses the 
prognosis was worse after iuMR including 13 in whom the prognosis had become 
‘Poor’. In the 14 cases in which the prognosis improved after iuMR, the prognosis was 
described as ‘Normal’ in three and ‘Favourable’ in six fetuses. TOP was offered to 
33/78 (42%) women on the basis of the USS findings alone (all from the ‘parenchymal 
abnormality’ group) and this increased to 45/78 (58%) after iuMR imaging (44 in the 
‘parenchymal abnormality’ group). In 28 cases TOP was offered both before and after 
iuMR imaging and in five cases the offer of TOP was reversed on the basis of the iuMR 
findings. TOP was offered on the basis of the iuMR findings alone in 17 cases. Hence, 
fundamental changes in the decision to offer TOP occurred in 22/78 cases (28%) and 
termination of pregnancy was performed in 16/78 (21%) cases. The effect of iuMR on 
the final choice of clinical management was considered to be: no influence – 8/78, 
minor influence – 43/78, significant influence – 16/78, major influence – 9/78 and 
decisive influence – 2/78. 
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DISCUSSION 
In this paper we present the last of three sub-group analyses from the MERIDIAN 
cohort, all of which were defined by the type of anatomical abnormality described on 
antenatal USS. The sub-groups were suggested by expert focus groups and consisted of 
the three commonest fetal neuropathologies encountered during antenatal USS; 
ventriculomegaly, failed commissuration and posterior fossa abnormalities. The subject 
of this report, posterior fossa abnormalities, is different from the other two in several 
ways - the first, and major, difference relates to how the sub-groups are formed. 
Ventriculomegaly is a single specific diagnosis relating to the size of the lateral 
ventricles (although it can result from a multitude of causes) and failed commissuration 
refers to varying degrees of underdevelopment of a single structure, the corpus 
callosum. In contrast, posterior fossa abnormalities form a heterogenous group with a 
range of different pathologies some of which are likely to be conspicuous on imaging, 
and hence easy to detect, whilst others will be more subtle. For example, Chiari 2 
malformation was detected accurately on USS and iuMR in all cases. In spite of specific 
examples such as that, the expert focus groups believed that the diagnosis of posterior 
fossa abnormalities is difficult on USS and iuMR imaging was likely to have a larger 
positive effect on diagnostic accuracy and confidence when compared with fetuses with 
ventriculomegaly or failed commissuration.  
 
The overall improvement in diagnostic accuracy of iuMR imaging over USS shown in 
this study was based on an approximately 23% increase (95% CI: 65 to 88%), double 
the rate of extra brain abnormalities being found in fetuses in the isolated 
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ventriculomegaly sub-group (10%)1. In contrast, the improvement in diagnostic 
accuracy for detecting posterior fossa abnormalities was substantially lower than the 
improvement in cases of failed commissuration, in which iuMR improved diagnostic 
accuracy from 34% to 95%. There was also a much clearer improvement in diagnostic 
confidence using iuMR imaging in the failed commissuration group compared with 
posterior fossa abnormalities, although the latter still showed a statistically significant 
improvement over USS. The comparative diagnostic performance of USS and iuMR 
imaging was closest for parenchymal abnormalities where USS had a diagnostic 
accuracy of 81% (when the nature of the posterior fossa pathology alone was 
considered) compared with 96% for iuMR, although the difference still indicates an 
improvement for iuMR imaging. One important confounding factor to consider when 
interpreting this data concerns the cases of Chiari 2 malformations. Those are posterior 
fossa parenchymal abnormalities and, hence, were eligible for recruitment into 
MERIDIAN but there is an invariable association between Chiari 2 malformation and 
open spinal dysraphism. The spinal pathology is often gross and easily detected on USS 
and could potentially bias the results by ‘signposting’ the presence of the Chiari 2 
malformation that would otherwise have been overlooked on antenatal USS. There were 
21 cases of Chiari 2 malformation in our sub-group and in all of those fetuses the USS, 
iuMR and ORD were all in agreement. If the fetuses with Chiari 2 malformations are 
excluded from analysis, the diagnostic accuracy for USS in detecting parenchymal 
abnormalities becomes 72% (33/46 correct) and for iuMR 93% (43/46 correct).  
 
Although the numbers in our sub-group with CSF-containing abnormalities were small 
(n=14), the diagnostic performance for both USS and iuMR in attempting to define 
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CSF-containing abnormalities is worryingly poor (diagnostic accuracy for USS 21%, 
diagnostic accuracy for iuMR 57%). This is the only diagnostic accuracy analysis of the 
MERIDIAN data performed to date that has failed to show a statistically significant 
improvement of iuMR over USS (p=0.0625), although this subgroup comprised just 14 
fetuses. The commonest error category in this group was a normal ORD report but both 
imaging modalities reporting an enlarged CM. It is interesting to speculate why the 
performance of both USS and iuMR imaging are poor for this particular type of 
pathology as there are no recognised specific technical or anatomical reasons to explain 
the sub-optimal performance. One possibility is the antenatal USS and iuMR 
examinations were correct at the time of the imaging studies in that enlarged CM is a 
temporary, but normal, feature in some fetuses which regresses and is no longer present 
in the neonate or infant10. Differential growth of the cerebellum/bony posterior fossa 
and postnatal changes in CSF resorption are possible mechanisms to explain this 
supposition. Another possibility is that the ORD is wrong and the reported enlarged CM 
are indeed abnormal and could be explained by the mechanism by which ORD was 
collected in this study. It was not possible to insist on postnatal MR examinations in this 
study, rather we had to rely on the neuroimaging that had been obtained for clinical 
purposes up to the age of 6 months. It is highly likely that most babies with enlarged 
CM as the only intracranial finding will have no evidence of neurodevelopmental 
problems and therefore postnatal MR examinations are unlikely to be requested.  As a 
result the only postnatal imaging will be trans-fontanelle cranial ultrasonography which 
is known to be poor at showing the posterior fossa11,12, particularly the extra-axial 
spaces. As such, an enlarged CM could be missed. Both of the suggestions to explain 
the poor performance of USS and iuMR imaging are easily testable and future imaging 
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studies could be designed to answer this question and the results will be important in 
terms of counselling given to a woman whose fetus has an enlarged CM.  
 
Even in its present form, however, the results of iuMR imaging had a substantial impact 
on prognostication and clinical management in cases of fetal posterior fossa 
abnormalities. The prognostic category changed in 44% of cases after iuMR imaging 
and in slightly more than half of those cases the prognosis was worse after iuMR. The 
overall effect of iuMR imaging was to increase the rate at which TOP was offered to 
women, approximately 42% on the basis of the USS findings alone to approximately 
58% after the iuMR imaging. Five women were offered TOP on the basis of USS but 
the offer reversed after iuMR imaging so the individual rate of changing the offer of 
TOP was 17/78 (approximately 22%).  The effects on clinical management were 
considered to be significant, major or decisive in 35% of pregnancies. 
 
The perceived problems about coming to the correct anatomical diagnosis of posterior 
fossa abnormalities using USS predicted by the expert focus groups were realised, as 
was the improvement brought about by supplementing the USS examination with iuMR 
scans. The improvements in diagnostic accuracy and confidence arising from 
performing iuMR studies was accompanied by changes of prognosis and clinical 
management in approximately 40% of cases.  We conclude, therefore, that iuMR 
imaging should be offered routinely to women whose fetus has a posterior fossa 
abnormality detected on antenatal USS.    
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Table 1 Cases of isolated abnormalities of the posterior fossa diagnosed on USS and the 
equivalent cases on iuMR compared with ORD. 
 
 
The subgroup ‘any abnormality of the posterior fossa’ allows any diagnosis of isolated 
posterior fossa abnormality to be correct when compared with ORD, whereas subgroups 
‘parenchymal’ and ‘CSF’ require the more restrictive diagnoses described in the text to be 
correct. * McNemar’s test between USS and iuMR correct diagnoses. 
 
 
 
 
 
 
 
 
 
 
 USS Diagnoses iuMR Diagnoses Comparison of 
diagnostic accuracy 
Subgroup 
n 
Number 
incorrect 
Diagnostic 
accuracy 
Number 
incorrect 
Diagnostic 
accuracy 
Difference 
(95% CI**) p-value* 
Any 
abnormality of 
the  posterior 
fossa 
81 28 65.4% 10 87.7% 22.3 (14.0, 
30.5%) 
<0⋅0001 
Parenchymal 
abnormality 
67 13 80.6% 3 95.5% 14.9 (5.7, 
24.1%) 
0.0020 
CSF 
abnormality 
14 11 21.4% 6 57.1% 35.7 (-1.6, 
73.0%) 
0.0625 
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Table 2 Summary data on the 28 cases in which posterior fossa abnormalities diagnosed on USS were incorrect when compared with outcome 
reference data from the first line of results in table 1.   
Case 
 
USS diagnosis Posterior fossa 
abnormality on ORD 
Other brain 
abnormality on ORD 
iuMR 
weeks 
Posterior fossa 
abnormality on iuMR 
Other brain 
abnormality on iuMR 
43 DWS DWS Hypoplasia CC 20 DWS *No 
55 Hypoplastic vermis Normal No 29 *Hypoplastic vermis No 
148 Hypoplastic vermis Normal No 21 *Hypoplastic vermis No 
170 DWS DWS Hypoplasia CC 21 DWS Hypoplasia CC 
230 Hypoplastic vermis Normal No 21 Normal No 
432 DWS Intracerebellar 
haemorrhage 
Periventricular 
leukomalacia 
35 Intracerebellar 
haemorrhage 
Periventricular 
leukomalacia 
466 Hypoplastic 
hemisphere. 
Hypoplastic hemisphere. Lissencephaly 29 Hypoplastic hemisphere. Lissencephaly 
506 Hypoplastic vermis Normal No 33 Normal No 
569 DWS DWS Focal megalencephaly 
(and agenesis CC) 
22 DWS Agenesis CC 
Focal megalencephaly 
578 DWS DWS Hypoplasia CC 21 DWS Hypoplasia CC 
700 Hypoplastic Normal No 28 *Hypoplastic No 
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hemisphere. hemisphere. 
726 Hypoplastic 
hemisphere. 
Rhombencephalosynapsis Hypoplasia CC 26 Rhombencephalosynapsis Hypoplasia CC 
739 Hypoplastic 
hemisphere. 
Normal No 23 Normal No 
765 Hypoplastic vermis Normal No 19 Normal No 
769 Hypoplastic vermis DWS Hypoplasia CC 20 DWS Hypoplasia CC 
777 DWS Normal No 33 Normal No 
855 Hypoplastic vermis Normal No 21 Normal No 
865 Hypoplastic vermis Normal No 35 Normal No 
1056 Hypoplastic vermis Normal No 22 Normal No 
97 Arachnoid cyst  Normal - Mass  
effect only 
Duro-venous sinus 
ectasia with thrombosis 
29 Mass effect only Duro-venous sinus ectasia 
with thrombosis 
281 Enlarged CM Normal No 21 *Enlarged CM No 
393 Posterior fossa cyst  Normal No 20 *Posterior fossa cyst No 
476 Posterior fossa cyst  Normal No 20 *Posterior fossa cyst No 
551 Enlarged CM Normal No 22 *Enlarged CM No 
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555 Enlarged CM Normal No 29 Normal No 
607 Enlarged CM Normal No 32 Normal No 
889 Enlarged CM Hypoplastic vermis Agenesis of the CC 26 *DWS *No 
1087 Enlarged CM Normal No 22 *Enlarged CM No 
 
* indicates that in utero MR imaging diagnosis was also incorrect. Abbreviations used: ORD = outcome reference data, DWS = Dandy-Walker 
spectrum, CC = corpus callosum, CM = cisterna magna 
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